MyChesCo on MSN14h
Teleflex Reports Promising Preliminary Results for Ringer PBC Study
Teleflex Incorporated (NYSE: TFX) has shared promising preliminary results from its Ringer™ PBC IDE study, featured in a ...
Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference
Prospective Multicenter Study Investigates Ringer™ PBC for Management of Coronary PerforationsWAYNE, Pa., March 27, 2025 ...
Teleflex reports efficacy of Ringer PBC in coronary procedures
Teleflex (TFX) announced that the preliminary results from its Ringer PBC IDE study were reported in a featured presentation at the CTO Plus ...
Becker's Hospital Review8d
AI cuts length of stay in half after angioplasty: 5 notes
The use of an AI-powered risk assessment tool cut the average length of stay for patients undergoing cardiac catheterization ...
Fierce Biotech4d
Abbott launches intravascular lithotripsy trial aimed at clearing coronary arteries
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
Pharmabiz2d
Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease
Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...
Daily Excelsior6d
SSH Jammu starts operation of Cath Lab
In a major relief for cardiac patients across Jammu and Kashmir, the Super Speciality Hospital (SSH) Jammu commenced ...
Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...